Genetic Analysis AS (XSAT:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.6300
-0.0080 (-1.25%)
At close: May 18, 2026

Genetic Analysis AS Company Description

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution.

The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Collection Kit used for collection, transport, and storage of fecal specimens for nucleic acid analyses; and GA-map Covid-19 Fecal Test, a non-invasive test with an easy-to-use home sampling procedure.

Further, it offers laboratory services; and bioinformatic analysis services. The company develops rapid microbiome-based PCR test.

Genetic Analysis AS was founded in 2008 and is headquartered in Oslo, Norway.

Genetic Analysis AS
CountrySweden
Founded2008
Employees16
CEORonny Hermansen

Contact Details

Address:
Ulvenveien 80B
Oslo
Norway
Phone47 48 32 16 10

Stock Details

Ticker SymbolGEAN
ExchangeSpotlight Stock Market
Fiscal YearJanuary - December
Reporting CurrencyNOK
SIC Code2835

Key Executives

NamePosition
Ronny HermansenChief Executive Officer
Lars TillerChief Operating Officer